1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : FINANCE (INCLUDING NBFCS)
  4. PIRAMAL ENTERPRISES LTD.
Piramal Enterprises Ltd. NSE: PEL | BSE: 500302
1131.30 31.10 (2.83%)
909.5K
NSE+BSE Volume

NSE 20 Jun, 2025 3:31 PM (IST)



Board Meetings - Piramal Enterprises Ltd.

The latest board meeting for Piramal Enterprises Ltd. took place on 06 May 2025, for the purpose of Audited Results & Final Dividend

Ex-date Purpose Notes
06 May 2025 Audited Results & Final Dividend -
27 Jan 2025 Quarterly Results -
23 Oct 2024 Quarterly Results -
13 Aug 2024 Quarterly Results -
08 May 2024 Audited Results & Final Dividend -
29 Jan 2024 Quarterly Results -
09 Nov 2023 Quarterly Results -
28 Jul 2023 Quarterly Results & Buy Back -
05 May 2023 Audited Results & Final Dividend -
08 Feb 2023 Quarterly Results -
09 Nov 2022 Quarterly Results -
29 Jul 2022 Quarterly Results -
14 Jul 2022 To consider raising of funds -
26 May 2022 Audited Results & Final Dividend -
10 Feb 2022 Quarterly Results -
11 Nov 2021 Quarterly Results -
06 Aug 2021 Quarterly Results -
13 May 2021 Audited Results & Final Dividend -
11 Feb 2021 Quarterly Results -
28 Oct 2020 Quarterly Results -
30 Jul 2020 Quarterly Results -
11 May 2020 Audited Results & Final Dividend -
18 Mar 2020 Interim Dividend -
04 Feb 2020 Quarterly Results -
25 Oct 2019 Preferential Issue of shares -
21 Oct 2019 Quarterly Results -
30 Jul 2019 Quarterly Results -
26 Apr 2019 Audited Results & Dividend -
28 Jan 2019 Quarterly Results -
18 Dec 2018 Others To consider amendment to the terms of issue of Non-convertible Debentures issued vide Information Memorandum dated November 15, 2018 and November 28, 2018.
25 Oct 2018 Quarterly Results -
30 Jul 2018 Quarterly Results -
28 May 2018 Audited Results & Dividend -
02 Apr 2018 Others Setting-up wholly owned subsidiaries of the company to commence business of Merchant banking and Asset Management.
30 Jan 2018 Quarterly Results -
06 Nov 2017 Quarterly Results -
12 Oct 2017 Raising of funds & SoA -
01 Aug 2017 Quarterly Results -
12 May 2017 Audited Results & Others To consider Raising of funds
13 Feb 2017 Quarterly Results -
27 Oct 2016 Quarterly Results -
25 Aug 2016 Others Approve the issue on private placement basis of secured non-convertible debentures aggregating to Rs. 80 crores in one or more issues from time to time.
01 Aug 2016 Quarterly Results -
10 Jun 2016 Others To approve the issue on private placement basis of Secured Non-Convertible Debentures amounting upto Rs. 300 crores.
16 May 2016 Audited Results -
09 Mar 2016 Interim Dividend -
29 Feb 2016 Others To consider and approve the issue on private placement basis of secured non-convertible debentures amounting upto Rs 1000 crores in one or more tranches from time to time.
08 Feb 2016 Quarterly Results -
02 Nov 2015 Quarterly Results -
06 Aug 2015 Quarterly Results -
07 May 2015 Audited Results & Dividend -
09 Feb 2015 Quarterly Results -
21 Oct 2014 Quarterly Results -
06 Aug 2014 Quarterly Results -
05 May 2014 Audited Results & Dividend -
30 Jan 2014 Quarterly Results -
23 Oct 2013 Quarterly Results -
25 Jul 2013 Quarterly Results -
03 May 2013 Audited Results & Dividend -
11 Feb 2013 Quarterly Results -
05 Nov 2012 Quarterly Results -
14 Aug 2012 Quarterly Results -
03 May 2012 Audited Results & Dividend -
02 Apr 2012 Change in name of the Company To change the name of the Company from Piramal Healthcare Limited to Piramal Enterprises Limited or such other name as maybe approved by the Registrar of Companies / other statutory authorities.
02 Feb 2012 Quarterly Results -
20 Oct 2011 Quarterly Results -
02 Aug 2011 Quarterly Results -
06 May 2011 Audited Results & Special Dividend For considering a proposal for Demerger of the New Chemical Entity (NCE) Research Unit of Piramal Life Sciences Ltd ('PLSL') into the Company. The Company has a 17.88% equity stake in PLSL.
11 Feb 2011 Quarterly Results -
22 Oct 2010 Qtrly Results, Dividend & Buy Back -
10 Aug 2010 Quarterly Results -
21 May 2010 Others The Board has granted its approval to the Company entering into a definitive agreement with Abbott (Abbott of Illinois, USA, for Abbott to acquire Piramals Domestic Formulations business.
07 May 2010 Audited Results & Dividend (Revised)
21 Jan 2010 Quarterly Results -
03 Dec 2009 Raising of funds by issue of Securities For raising funds upto an amount of Rs. 1000 Crs through an issue of Equity / Equity-linked Securities, subject to requisite approvals.
22 Oct 2009 Quarterly Results -
22 Jul 2009 Quarterly Results -
24 Apr 2009 Audited Results & Dividend -
22 Jan 2009 Quarterly Results -
22 Oct 2008 Quarterly Results -
24 Jul 2008 Quarterly Results -
24 Apr 2008 Audited Results -
18 Jan 2008 Quarterly Results -
25 Oct 2007 Quarterly Results -
31 Aug 2007 Scheme of Arrangement -
25 Jul 2007 Quarterly Results -
26 Apr 2007 Audited Results -
15 Mar 2007 Interim Dividend -
18 Jan 2007 Quarterly Results -
18 Oct 2006 Quarterly & Half Yearly Results -
20 Jul 2006 Quarterly Results -
25 Apr 2006 Accounts & Raising of funds The Board will also discuss raising of resources through appropriate securities.
19 Jan 2006 Quarterly Results -
20 Oct 2005 Quarterly Results -
29 Jul 2005 Quarterly Results & Accounts -
26 Apr 2005 Accounts -
12 Mar 2005 Others To consider various options to raise funds domestically/internationally from existing and/or new investors.
21 Jan 2005 Quarterly Results -
17 Dec 2004 Others Approved the acquisition of the global inhalation Anaesthetics (IA) business of Rhodia Organique Fine Ltd (Rhodia), U.K.,
21 Oct 2004 Quarterly Results -